BioSpace News Archive

The Leona M. and Harry B. Helmsley Charitable Trust announced today a multimillion-dollar effort to save the lives of COVID-19 patients and protect the frontline healthcare workers caring for them.

Conformis, Inc. (NASDAQ:CFMS) today announced that on April 17, 2020 the Company entered into a $4,719,800 promissory note with East West Bank (NASDAQ:EWBC) under the Paycheck Protection Program (“PPP”) offered by the U.S. Small Business Administration (the “SBA”) to mitigate the negative financial and operational impacts of the coronavirus (COVID-19) pandemic.

The pharmaceutical company PharmaNutra S.p.A. (Aim Italia -Ticker PHN), leader in the iron-based, nutritional supplements sector, reports on an important new scientific and commercial agreement for the innovative Sucrosomial® Technology patented by the Group.

Avtar Dhillon, M.D., Resigns as Chair of the Board; Current Board Member, Margaret R. Dalesandro, Ph.D., Assumes the Role of Chair

Pi-Cardia Ltd., a global leader in the development of non-implant catheter-based solutions for treating heart valve calcification, announced today it has closed a $27 million round of financing, led by Sofinnova Partners, a leading European life sciences venture capital firm, and joined by Professor Jacques Séguin , Chairman of

Stero Biotechs, an Israel-based, clinical-stage company focused on Cannabidiol (CBD) formulation research and development, in a collaboration with its main partner and shareholder, Mor Research Applications, the Tech Transfer Office (TTO) of the largest Health Maintenance Organiztaion (HMO) in Israel – Clalit, announced today a new clinical trial in the global efforts of fighting the COVID-19 virus.

Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company with a track record of more than 100 years and a recognized leader in the development and production of plasma-derived medicines, today announced it has begun identifying, screening and selecting volunteer donors who have recovered from COVID-19 to donate their plasma in select U.S. cities.

PDI Healthcare, a global leader in infection prevention products and solutions, is testing several of its disinfectant products for efficacy against SARS-CoV-2, the virus that causes COVID-19, for submission to the EPA for approval.

Multi-Quadrupole ICP-MS, FT-IR and automation innovations provide testing and research performance, flexibility and ease of use

Biologics by McKesson , an independent specialty pharmacy for oncology and other rare and complex therapeutic areas, has been selected by Seattle Genetics as a specialty pharmacy provider for TUKYSA TM (tucatinib) for the treatment of HER2-positive breast cancer. TUKYSA, approved by the FDA on April 17, 2020, is an orally bioavailable, small molecule tyrosine kinase inhibitor (TKI) that is highly selective for HER2, a